Regulated information

H1 2022 Sales

H1 2022 Sales: €271m, up 6.1%
+2.0% on a like-for-like basis
H1 2022 Essentials Sales: €154m, up 9.8%
+6.8% on a like-for-like basis

Buyback programs - may 2022

Monthly communication regarding buyback programs

Buyback programs - april 2022

Monthly communication regarding buyback programs

Availability of the 2021 universal registration document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

Q1 2022 SALES: €135M

Q1 2022 SALES: €135M
(UP 5.5% AS REPORTED, UP 2.2% AT CONSTANT EXCHANGE RATES)
Q1 2022 ESSENTIALS SALES: €77M
(UP 8.1% AS REPORTED, UP 5.5 AT CONSTANT EXCHANGE RATES)

Buyback programs - march 2022

Monthly communication regarding buyback programs

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

Annual results 2021 (slideshow)

This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022.

[AUDIO] Présentation des résultats 2021

Présentation analystes & investisseurs - 24 mars 2022

Buyback programs - february 2022

Buyback programs - February 2022